版本:
中国

BRIEF-Pfizer begins Phase 1 clinical trial to evaluate investigational Group B streptococcus vaccine

June 19 Pfizer Inc

* Pfizer begins Phase 1 clinical trial to evaluate investigational Group B streptococcus vaccine

* Pfizer Inc - trial will be conducted in United States Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐